Status | Study |
Withdrawn |
Study Name: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation Condition: Prolymphocytic Leukemia Recurrent Mantle Cell Lymphoma Rec Date: 2014-11-04 Interventions: Drug: sotrastaurin acetate Giv |
Terminated |
Study Name: Selinexor in Initial or Relapsed/Refractory Richter's Transformation Condition: Richter's Transformation Date: 2014-05-13 Interventions: Drug: selinexor 60 mg, may be increased to 80 mg after Cycle 1 |
Active, not recruiting |
Study Name: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia Condition: Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Date: 2014-01-06 Interventions: Drug: acalabrutinib |
Recruiting |
Study Name: Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL Condition: Contiguous Stage II Small Lymphocytic Lymphoma Noncontiguous Stage II Small Lymphocytic Lymp Date: 2013-12-03 Interventions: Biological: MOR00208 Given by |
Completed |
Study Name: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL Condition: B-cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Date: 2010-10-07 Interventions: Drug: PCI-32765 420 mg PO dail |
Recruiting |
Study Name: Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome Condition: Richter's Syndrome Date: 2010-07-22 Interventions: Drug: Ofatumumab 1000mg vials (50ml @ 20mg/ml), or 100mg v |
Completed |
Study Name: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias Condition: Richter's Transformation Leukemia Date: 2007-05-11 Interventions: Drug: Oxaliplatin Oxaliplatin |
Completed |
Study Name: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL Condition: Leukemia Date: 2007-03-23 Interventions: Drug: Cytarabine 1 g/m^2 given |
Completed |
Study Name: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) Condition: Chronic Lymphocytic Leukemia Date: 2006-03-29 Interventions: Biological: rituximab Drug: cyclophosphami |
Completed |
Study Name: VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders Condition: Leukemia Lymphoma Date: 2006-03-15 Interventions: Drug: laromustine |